Journal article

Novel agents versus chemotherapy as frontline treatment of CLL

Anna Piggin, Emma Bayly, Constantine S Tam

Leukemia & Lymphoma | TAYLOR & FRANCIS LTD | Published : 2017

DOI: 10.1080/10428194.2017.1280606

Citation metrics

3Web of Science
3Scopus
3Dimensions

Keywords

Hematology
Life Sciences & Biomedicine
Obinutuzmab
Clinical Trials As Topic
Chronic Lymphocytic-Leukemia
Idelalisib
Oncology
Humans
Comorbidity
Protein Kinase Inhibitors
Cyclophosphamide
Chromosome Deletion
Female
Male
Open-Label
Initial Therapy
Chromosomes, Human, Pair 11
Phase-3 Trial
Leukemia, Lymphocytic, Chronic, B-Cell
Immunoglobulin Heavy Chains
Science & Technology
Rituximab
Chromosomes, Human, Pair 13
Previously Untreated Patients
Venetoclax
Immunotherapy
Pyrimidines
Chemoimmunotherapy
Mutation
Treatment Outcome
Aged
Middle Aged
Molecular Targeted Therapy
Ibrutinib
Antineoplastic Combined Chemotherapy Protocols
Fludarabine
Pyrazoles